Mineralys Therapeutics
MLYS
#6386
Rank
$0.61 B
Marketcap
$12.34
Share price
4.31%
Change (1 day)
52.53%
Change (1 year)

Earnings for Mineralys Therapeutics (MLYS)

Earnings in 2024 (TTM): -$0.16 Billion USD

According to Mineralys Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -$71.9 Million USD a decrease over its 2022 earnings that were of -$29.8 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Mineralys Therapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$0.16 Billion113.15%
2023 -$71.9 Million141.28%
2022 -$29.8 Million